Simplex Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-328
Closed -$6K – 11062
2022
Q2
$6K Buy
328
+323
+6,460% +$8.08K ﹤0.01% 8764
2022
Q1
$0 Buy
+5
New +$180 ﹤0.01% 11567
2021
Q4
– Sell
-718
Closed -$37.8K – 11630
2021
Q3
$62K Buy
718
+3
+0.4% +$213 ﹤0.01% 7270
2021
Q2
$62K Buy
715
+217
+44% +$20.6K ﹤0.01% 7391
2021
Q1
$56K Buy
498
+497
+49,700% +$55.1K ﹤0.01% 6475
2020
Q4
$0 Buy
+1
New +$37 ﹤0.01% 9213
2019
Q2
– Sell
-48
Closed -$16.9K – 7927
2019
Q1
$22K Buy
48
+43
+860% +$16.7K ﹤0.01% 5661
2018
Q4
$1K Buy
+5
New +$1.2K ﹤0.01% 6809
2018
Q2
– Sell
-3
Closed -$553 – 7976
2018
Q1
$0 Sell
3
-70
-96% -$13.7K ﹤0.01% 6999
2017
Q4
$17K Sell
73
-82
-53% -$17.1K ﹤0.01% 3462
2017
Q3
$31K Buy
+155
New +$28.5K ﹤0.01% 2764
2016
Q4
– Sell
-129
Closed -$44K – 6660
2016
Q3
$44K Buy
129
+50
+63% +$17.5K ﹤0.01% 2213
2016
Q2
$25K Buy
+79
New +$28.4K ﹤0.01% 2712

Other funds holding CSCI

Simplex Trading's CSCI Position: Q3 2022 in Review

Simplex Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 328 shares — an estimated $6K sold.

Simplex Trading first reported a position in CSCI in Q2 2016 and held it in 13 quarters. The position peaked at $62K in Q3 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

  • Simplex Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Simplex Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 13 quarters.
  • Simplex Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $62K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.